Viruses (Sep 2021)

Clinical Evaluation of In-House-Produced 3D-Printed Nasopharyngeal Swabs for COVID-19 Testing

  • Simon Grandjean Lapierre,
  • Stéphane Bedwani,
  • François DeBlois,
  • Audray Fortin,
  • Natalia Zamorano Cuervo,
  • Karim Zerouali,
  • Elise Caron,
  • Philippe Morency-Potvin,
  • Simon Gagnon,
  • Nakome Nguissan,
  • Pascale Arlotto,
  • Isabelle Hardy,
  • Catherine-Audrey Boutin,
  • Cécile Tremblay,
  • François Coutlée,
  • Jacques de Guise,
  • Nathalie Grandvaux

DOI
https://doi.org/10.3390/v13091752
Journal volume & issue
Vol. 13, no. 9
p. 1752

Abstract

Read online

3D-printed alternatives to standard flocked swabs were rapidly developed to provide a response to the unprecedented and sudden need for an exponentially growing amount of diagnostic tools to fight the COVID-19 pandemic. In light of the anticipated shortage, a hospital-based 3D-printing platform was implemented in our institution for the production of swabs for nasopharyngeal and oropharyngeal sampling based on the freely available, open-source design provided to the community by University of South Florida’s Health Radiology and Northwell Health System teams as a replacement for locally used commercial swabs. Validation of our 3D-printed swabs was performed with a head-to-head diagnostic accuracy study of the 3D-printed “Northwell model” with the cobas PCR Media® swab sample kit. We observed an excellent concordance (total agreement 96.8%, Kappa 0.936) in results obtained with the 3D-printed and flocked swabs, indicating that the in-house 3D-printed swab could be used reliably in the context of a shortage of flocked swabs. To our knowledge, this is the first study to report on autonomous hospital-based production and clinical validation of 3D-printed swabs.

Keywords